It aims to broaden the understanding of L-arg metabolism as a novel and promising driver of vascular biology, particularly in vascular regeneration and tumor angiogenesis, while also raising new questions in the field of amino acid metabolism as potential targets for controlling physiological and pathological angiogenesis. This evidence concerns the gene ARHGEF12 and neoplasm.